| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.96M | 32.03M | 14.93M | 19.51M | 13.49M | 11.22M |
| Gross Profit | 30.38M | 30.29M | 13.63M | 17.81M | 11.99M | 9.66M |
| EBITDA | 29.14M | 29.15M | 7.77M | 16.45M | 11.64M | 8.89M |
| Net Income | 20.16M | 17.06M | 17.26M | 9.82M | 7.25M | 5.62M |
Balance Sheet | ||||||
| Total Assets | 396.87M | 411.77M | 253.57M | 224.03M | 265.82M | 220.19M |
| Cash, Cash Equivalents and Short-Term Investments | 3.13M | 8.63M | 0.00 | 72.09M | 87.00K | 64.00K |
| Total Debt | 124.42M | 150.56M | 71.37M | 56.97M | 110.08M | 101.11M |
| Total Liabilities | 142.65M | 168.38M | 81.25M | 68.77M | 119.50M | 109.67M |
| Stockholders Equity | 226.35M | 216.34M | 148.50M | 132.66M | 124.58M | 93.33M |
Cash Flow | ||||||
| Free Cash Flow | 5.14M | 3.14M | 2.71M | 845.00K | -5.58M | 19.34M |
| Operating Cash Flow | 5.14M | 3.14M | 2.71M | 845.00K | 1.99M | 1.14M |
| Investing Cash Flow | -25.60M | -104.41M | -9.59M | 55.46M | -37.94M | -6.26M |
| Financing Cash Flow | 23.57M | 101.53M | 6.88M | -56.39M | 35.97M | 5.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | C$193.65M | 4.76 | 13.95% | ― | 7.07% | -3.06% | |
72 Outperform | C$548.84M | 7.93 | 4.65% | 3.14% | 29.55% | 425.60% | |
69 Neutral | C$154.74M | 13.14 | 9.09% | ― | 70.08% | -20.96% | |
66 Neutral | C$236.32M | 8.72 | 8.37% | 8.65% | 2.69% | -45.80% | |
66 Neutral | C$523.53M | 10.56 | 17.19% | ― | -4.02% | 34.29% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
45 Neutral | C$314.26M | -2.20 | -16.57% | 5.65% | -1.06% | -20.07% |